1. Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers
   S. K. Goswami et al, 2016, Journal of Pharmacology and Experimental Therapeutics CrossRef
2. Emu Oil Reduces Small Intestinal Inflammation in the Absence of Clinical Improvement in a Rat Model of Indomethacin-Induced Enteropathy
   Suzanne M. Abimosleh et al, 2013, Evidence-Based Complementary and Alternative Medicine CrossRef
3. The non-invasive exfoliated transcriptome (exfoliome) reflects the tissue-level transcriptome in a mouse model of NSAID enteropathy
   Canaan M. Whitfield-Cargile et al, 2017, Scientific Reports CrossRef
4. NSAID-Associated Small Intestinal Injury: An Overview From Animal Model Development to Pathogenesis, Treatment, and Prevention
   Mingyu Zhang et al, 2022, Frontiers in Pharmacology CrossRef
5. Bidirectional interactions between indomethacin and the murine intestinal microbiota
   Xue Liang et al, 2015, eLife CrossRef
6. A quinazoline‐based bromodomain inhibitor, CN210, ameliorates indomethacin‐induced ileitis in mice by inhibiting inflammatory cytokine expression
   Takehisa Noguchi et al, 2021, Drug Development Research CrossRef
7. Small molecule FAK activator promotes human intestinal epithelial monolayer wound closure and mouse ulcer healing
   Qinggang Wang et al, 2019, Scientific Reports CrossRef
8. Galectin-3 as a Therapeutic Target for NSAID-Induced Intestinal Ulcers
   Ah-Mee Park et al, 2020, Frontiers in Immunology CrossRef
9. Gut Microbiota in NSAID Enteropathy: New Insights From Inside
   Xianglu Wang et al, 2021, Frontiers in Cellular and Infection Microbiology CrossRef